However, regain exceeding 12 pounds per week signals that hunger is outpacing your behavioral controls and may warrant pausing your taper or adjusting your dietary strategy
This week was also the week that an afternoon snack consisting of almonds and fruit wore real thin
Risk Factors History of stomach issues or motion sickness Rapid dose increases Starting at higher doses Large, high-fat meals Eating too quickly Dehydration Existing metabolic disorders or obesity Female gender (noted in some studies) Metabolic disorders such as obesity exacerbate nausea
A great place to start
If approved, we believe pemvidutide could offer an important option for obesity patients, including those with risk factors for cardiovascular disease. However, tolerability issues remain, as the trial led to one participant experiencing vomiting, and 4.1% of the patients in the drug cohort discontinuing treatment in the first 16 weeks, when compared to 2.1% in the placebo group
Thats when side effects often spike: Nausea Bloating Stomach pain Fatigue References: U.S